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Abstract: The blood-brain barrier (BBB), composed of brain microvascular endothelial cells (BMEC)
that are tightly linked by tight junction (TJ) proteins, restricts the movement of molecules between the
periphery and the central nervous system. Elevated systemic levels of neutrophils have been detected
in patients with altered BBB function, but the role of neutrophils in BMEC dysfunction is unknown.
Neutrophils are key players of the immune response and, when activated, produce neutrophil-derived
microvesicles (NMV). NMV have been shown to impact the integrity of endothelial cells throughout
the body and we hypothesize that NMV released from circulating neutrophils interact with BMEC
and induce endothelial cell dysfunction. Therefore, the current study investigated the interaction of
NMVwith human BMEC and determined whether they altered gene expression and function in vitro.
Using flow cytometry and confocal imaging, NMV were shown to be internalized by the human
cerebral microvascular endothelial cell line hCMEC/D3 via a variety of energy-dependentmechanisms,
including endocytosis and macropinocytosis. The internalization of NMV significantly altered the
transcriptomic profile of hCMEC/D3, specifically inducing the dysregulation of genes associated
with TJ, ubiquitin-mediated proteolysis and vesicular transport. Functional studies confirmed NMV
significantly increased permeability and decreased the transendothelial electrical resistance (TEER)
of a confluent monolayer of hCMEC/D3. These findings indicate that NMV interact with and affect
gene expression of BMEC as well as impacting their integrity. We conclude that NMV may play an
important role in modulating the permeability of BBB during an infection.
Keywords: neutrophils; microvesicles; blood brain barrier; endothelial cells; TEER; gene
expression; permeability
1. Introduction
The blood brain barrier (BBB) plays an integral role in maintaining central homeostasis by acting
as a physical barrier between the central nervous system (CNS) and the periphery. It is formed by
capillary endothelial cells, the basement membrane and surrounding pericytes and astrocyte endfeet,
this highly specialised structure exhibits high transendothelial electrical resistance (TEER) and restricts
the paracellular movement of molecules. Disruption, with increased permeability, of the BBB is a
feature of many neurodegenerative diseases, including Alzheimer’s disease (AD), vascular dementia
(VaD), and multiple sclerosis [1–3].
Int. J. Mol. Sci. 2019, 20, 5227; doi:10.3390/ijms20205227 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2019, 20, 5227 2 of 17
Continuous peripheral activation of the immune system during systemic infection can affect
the CNS and activate microglia, the resident immune cells [4]. Clinical studies have reported that
peripheral infection and systemic inflammation lead to the progression of cognitive decline in AD [5–7].
Chronic inflammatory conditions such as atherosclerosis [8,9], obesity [10], and periodontitis [11] are
either risk factors for and/or associated with late-onset AD. Animal models have also demonstrated
that peripheral activation of immune cells by inflammatory stimuli such as lipopolysaccharide (LPS)
can impact BBB permeability, increasing microglial activation [12–16]. Together, these studies support
a role for systemic inflammation in modulating BBB function and increasing neuroinflammation within
the CNS.
Neutrophils are the most abundant white blood cells in the circulation and act as the first line
of defense through various mechanisms, including the rapid production of reactive oxygen species,
phagocytosis, degranulation and release of extracellular traps. Neutrophil depletion in transgenic
murine models of AD reduces AD-like pathology by reducing amyloid-β deposits and improves
cognition in mice [17]. Patients with dementia have significantly higher levels of circulating neutrophils
than non-neurological controls [18], and their activation status correlates with AD progression [19].
While these studies indicate a role for neutrophils in AD, neutrophil extravasation is not routinely
associated with AD pathology, and the effect of neutrophils on the BBB is currently unknown.
There is increasing evidence that cells use plasma membrane-derived microvesicles (MV) to
communicate with distant target cells [20,21]. Neutrophils produce low levels of neutrophil-derived
microvesicles (NMV) under normal physiological conditions [22]. However, elevated levels of NMV
have been reported under inflammatory conditions [22–24]. NMV vary in size, ranging from 100 to
1000 nm indiameter, andhave adouble layeredmembrane [25,26]. They contain a range of inflammatory
proteins, mRNA, microRNA and adhesion molecules such as CD11a and L-selectin [27,28]. NMV
have been shown to impair the integrity of other endothelial cells such as human coronary arterial
endothelial cells (HCAEC) [29], human umbilical vein endothelial cells (HUVEC) [30] and other
myeloid cells [31], but their effects on BMEC are unknown.
The current study tested the hypothesis that in response to systemic infectionNMVare internalized
by BMEC, altering their integrity. Specifically, the study aimed to determine whether NMV interact
with BMEC, their mechanism of internalization and NMV-induced transcriptomic changes in brain
endothelial cells.
2. Results
2.1. Characterization of NMV
NMV isolated from the blood of healthy volunteers were analyzed using ZetaView
nanoparticle tracking analysis (NTA) revealed they were heterogenous with a mean size of
226 nm (Figure 1A), confirming previous characterization studies carried out in our laboratory [29].
The majority of NMV were in the range of 100–300 nm in diameter. NMV isolated from
N-formylmethionine-leucyl-phenylalanine (fMLP)-stimulated peripheral blood neutrophils were
further characterized using flow cytometry. As MV express molecules characteristic of the parent cell,
we analyzed the expression of the neutrophil specific surface antigen CD66b, detecting expression
in 57.2 ± 18.87% NMV (Figure 1B). In addition, NMV were stained for annexin V (Figure 1C),
demonstrating expression of phosphatidylserine on the surface of NMV, as described for other MV
preparations [31–33]. Furthermore, there was no detectable contamination by CD14-positive MV,
confirming negligible contamination with monocyte MV (Figure 1D).
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Figure 1. Characterization of neutrophil-derived microvesicles (NMV) internalization by hCMEC/D3.
(A) NMV size distribution were measured using ZetaView nanoparticle tracking analysis. NMV express
(B) the neutrophil surface antigen CD66b and (C) annexin V, but not (D) CD14 (monocytes), as detected
by flow cytometry. Isotype control was used to gate for CD66b and CD14 positivity, unlabeled NMVs
were used to set the gate for Annexin V positivity. Histograms are representative of three individual
neutrophil isolations.
2.2. NMV Are Internalised by Human Brain Endothelial Cells
Confocal laser microscopy revealed that fluorescently labelled NMV interacted with a confluent
monolayer of hCMEC/D3 cells (Figure 2A). Orthogonal views confirmed the internalization of NMV by
brain endothelial cells, detected within 2 h of incubation. To determine whether NMV colocalized with
early endosomes, hCMEC/D3 cells were stained with antibodies against early endosome antigen-1
(EEA-1). After 2 h incubation, a proportion of NMV was found to be associated with early endosomes
(Figure 2B). The internalization of NMV by hCMEC/D3was validated and quantified by flow cytometry
following the quenching of surface fluorescence using trypan blue. Fluorescently labelled NMV were
detected in 48.36 ± 11.37% of brain endothelial cells (Figure 2C–F).
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Figure 2. Internalization of NMV by hCMEC/D3. (A) NMV interaction was visualized using
confocal microscopy. PKH-26- NMV (red) were incubated with hCMEC/D3 for 2 h, fixed and stained
(FITC-phalloidin (green) and Topro-3-iodide (blue). Orthogonal views demonstrated the presence of
NMV inside the cells. Images were obtained on Zeiss LSM 510 confocal and 63×/1.4 oil immersion
lens. (B) Confocal analysis of hCMEC/D3 stained for EEA-1 antigen (red), PKH-67 NMV (green) and
counter-stained for nuclei (blue). Zeiss LSM 880 with Airyscan with a 63× oil immersion lens was used
to obtain the images. Zoomed in image (50%). (C) PKH-67- NMV were incubated with hCMEC/D3 for
2 h and cells analyzed for fluorescence by flow cytometry. Trypan blue (1 mg/mL) was added to the
sample immediately prior to analysis. Fluorescence intensity of unlabeled endothelial cells was used as
a parameter to set the threshold for PKH-67-positivity and to gate-out any cellular autofluorescence. (D)
hCMEC/D3 incubated with PKH-67 NMV after 2 h (E) Representative histogram of florescence intensity
of hCMEC/D3 cells with and without NMV. (F) Mean Fluorescence Intensity (MFI) was calculated using
FlowJo software (FlowJo v10.3). Results represent mean ± SD (n = 5, **** p < 0.0001, Unpaired t-test).
2.3. The Internalization of NMV Occurs via Multiple Pathways
Incubation of hCMEC/D3 with NMV at 4 ◦C significantly decreased the internalization of NMV
by 94.65 ± 0.81%, p-0.0001 (Figure 3B), demonstrating that this is an energy-dependent process. NMV
internalization was significantly reduced by 51.51 ± 7.219%, p-0.003 (Figure 3A) after the addition of
the chelating agent Ethylenediaminetetraacetic Acid (EDTA), indicating that the internalization is metal
ion-dependent. Stimulation of hCMEC/D3 with LPS or TNF-α had no effect on NMV internalization
(Figure 3C). Pre-treatment with proteinase K, a broad specificity protease, significantly reduced
internalization by 88.51 ± 3.619%, p-0.0001 (Figure 3D), suggesting protein–protein interaction is
needed for internalization of NMV.
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Figure 3. Mechanisms of NMV internalization by hCMEC/D3 cells. (A) Co-incubation with EDTA,
a metal ion chelator significantly reduced internalization. (B) NMV internalization was significantly
reduced at 4 ◦C. (C) Pre-incubation with LPS (1 µg/mL) and TNF-α (10 ng/mL) did not affect
internalization. (D) hCMEC/D3 cells were pre-incubated with pharmacological inhibitors genistein,
wortmannin, MDC, EIPA, cytochalasin D, Dynasore, and also proteinase K and PKH-67 labeled NMV
were added for 2 h. Data represent 3–5 independent experiments and are presented as the percentage
of NMV uptake compared to the positive control with no inhibitors (mean ± SD, One-way ANOVA
with Dunnett’s multiple comparison test * p < 0.05, *** p < 0.001, **** p < 0.0001).
To determine other possible cellular uptake mechanisms responsible for NMV internalization,
cells were treated with various pharmacological inhibitors, including: dynasore to inhibit the
function of dynamin, cytochalasin D to inhibit actin elongation and the formation of microfilaments,
5-(N-Ethyl-N-isopropyl)amiloride (EIPA) to block the activity of Na+/H+ exchangers required for
micropinocytosis, monodansylcadaverine (MDC) to inhibit clathrin-mediated endocytosis, and
genistein to inhibit caveolin-mediated endocytosis. The largest reduction in internalization was
seen with Dynasore (59.79 ± 5.01%, p-0.0001), followed by cytochalasin D (59.05 ± 13.35%, p-0.0001)
and EIPA (49.47 ± 9.908%, p-0.0001) (Figure 3D). MDC significantly reduced internalization by 39.55 ±
17.51%, p-0.0004, while genistein and wortmannin had a moderate effect (25.83 ± 14.08%, p-0.0374
and 25.95 ± 16.61%, p-0.0229, respectively). Varying levels of internalization inhibition resulting from
targeting these differing pathways suggests that NMV uptake occurs via multiple pathways.
2.4. Internalization of NMV Impacts the Transcriptomic Profile of Brain Endothelial Cells
While NMV are internalized after 2 h, the time to impact mRNA expression is likely longer.
Therefore transcriptomic analysis of hCMEC/D3 after 24 h incubation with NMV was performed using
Human Genome U133 Plus 2.0 Arrays, which contain at least one probe for each gene and recognize
over 39,000 genes. Principal component analysis confirmed there were no sample outliers (Figure 4A)
and QC were within an acceptable range. As shown in the heat map (Figure 4B), the internalization of
NMV significantly altered the gene expression profile of hCMEC/D3.
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Figure 4. Internalization of NMV significantly impacts the transcriptome of hCMEC/D3. (A) Principal
component analysis of microarray data. (B) Heat map depicting up-regulated (red) and down-regulated
(green) gene expression changes (FC≥ 1.2, p≤ 0.05), 932 genes were significantly differentially expressed
(363 up-regulated genes and 569 down-regulated genes). Blue bars represent untreated BMEC samples
while the black bars represent BMEC treated with NMV.
After setting the parameters as fold change ≥ 1.2, p value ≤ 0.05, 932 genes were significantly
differentially expressed (363 upregulated and 569 downregulated) (GEO public database accession code
GSE137111). Functional grouping analysis with the highest stringency setting identified dysregulated
genes that were associated with TJ proteins, ubiquitin-mediated proteolysis, vesicular transport and
metal cluster binding (Table 1).
Table 1. Functional grouping analysis of microarray data using Database for Annotation Visualization
and Integrated Discovery (DAVID).
Functional Group p-Value Number of Genes
Tight junction proteins 0.0062 6
Vesicle mediated transport 0.0074 19
Protein transport 0.0019 18
RNA localization 0.0011 9
Metal cluster binding 0.032 4
FY-rich terminals 0.0043 3
Kyoto encyclopedia of genes and genomes or KEGG pathway analysis in Database for Annotation
Visualization and Integrated Discovery (DAVID) and IMPaLA identified dysregulated pathways
including ubiquitin mediated proteolysis, SNARE mediated vesicular transport and the P38 pathway
(Table 2), demonstrating NMV significantly affect the gene expression of major pathways involved in
cellular functions in brain endothelial cells.
Table 2. KEGG pathway analysis of microarray data using DAVID and IMPaLA.
Pathway p-Value
Ubiquitin-mediated proteolysis 0.034
SNARE-mediated vesicular transport 0.0163
P38 pathway/Regulation of SMAD2/3 signaling 0.0191
Coenzyme B biosynthesis 0.0209
Gap junction degradation 0.0324
2.5. NMV Increase the Permeability and Decrease the Transendothelial Electrical Resistance of hCMEC/D3
As the microarray data indicated that the internalization of NMV impacts genes associated with
vascular integrity, we sought to validate this finding by assessing the effect of NMV on the permeability
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of a confluent monolayer of hCMEC/D3. To study the impact of NMV on paracellular leakage, 10 kDa
and 70 kDa FITC-dextran were employed to investigate the effect of NMV on the paracellular transport
of small and large molecules, respectively. When the paracellular flux of 10 kDa was investigated,
there was a significant increase in flux of 10 kDa FITC-dextran to the basolateral chamber (40.8 ± 3.3%,
p-0.0024). LPS, which disrupts the endothelial monolayer [34,35], was used as a positive control and
significantly increased the flux of 10 kDa FITC-dextran (36.6 ± 5.3%, p-0.0034) (Figure 5A). Similarly,
paracellular flux of 70 kDa FITC-dextran was significantly increased when NMV were present (20.9 ±
4.8%, p-0.0272) (Figure 5B), whilst LPS had no significant effect (Figure 5B).

 
Figure 5. NMV significantly increase the permeability and decrease the electrical resistance of a
hCMEC/D3 monolayer. NMV significantly increase the flux of (A) 10 kDa dextran and (B) 70 kDa
dextran across a confluent monolayer of hCMEC/D3. (C) NMV significantly decrease TEER within 3
h. Data represent 3 independent experiments, expressed as mean ± SD. Statistical significance was
measured using one-way ANOVA, * p < 0.05, ** p < 0.01, **** p < 0.0001.
In addition to assessing the effect of NMV on dextran permeability, we also measured TEER, as
a quantitative measure of barrier integrity. The internalization of NMV induced a time-dependent
effect on the permeability of the cell monolayer in vitro, NMV induced a decrease in the TEER of
the confluent monolayer within the first hour and, during the subsequent hours, TEER continued to
decrease (Figure 5C). Within 3 h, this decrease in TEER was statistically significant (p-0.0083). LPS
was used as a positive control and decreased TEER throughout the time-course (p-0.093). No cell
detachment was observed during the 6 h of this experiment.
3. Discussion
The inflammatory signals produced in response to systemic infection may increase BBB
permeability and disrupt homeostasis in the CNS leading to neuroinflammation and neuronal
dysfunction, exacerbating neurodegenerative processes [5,7,36–38]. However, the mechanisms by
which peripheral immune activation impacts the CNS remain relatively unknown. In the current study,
we demonstrate that NMV are internalized by human brain endothelial cells in vitro, significantly
altering the transcriptomic profile and leading to increased monolayer permeability, suggesting a
mechanism whereby the peripheral response to infection can induce BMEC dysfunction.
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While extravasated neutrophils are not routinely associated with age-related neuropathology
and are not usually detected in the brain, individuals with dementia have significantly higher levels
of circulating neutrophils than neurological controls [18]. Conflicting reports have suggested that
neutrophils from patients with dementia have a reduced immune response [39], while others have
indicated neutrophil hyperactivation correlates with the progression of AD [19]. The current study
isolated peripheral-blood neutrophils and identified a potential mechanism whereby neutrophils
can alter the function of the BMEC. Neutrophils were stimulated with fMLP, a bacterial peptide,
to induce MV formation using a well-characterized, standard protocol [25,29,40,41], and NMV
were characterized using nanoparticle tracking and annexin V staining, indicating the presence of
phosphatidylserine [25,28,30,32]. NMV also expressed CD66b, demonstrating that it originated from
neutrophils although heterogeneity in CD66b expression is reported in the literature [25,32,42,43].
CD66b is an important surface marker expressed on neutrophils and is involved in adherence of
neutrophils to endothelial cells [44]. The expression of this molecule on the surface of NMVmay aid in
adhesion to brain endothelial cells, although detailed work is needed to understand how NMV adhere
to the cells.
Uptake of MV originating from other cell types such as monocytes, platelets, and cancer cells
has been widely reported [32,43,45–47], but to our knowledge, this is the first study to report the
internalization of NMV by human brain microvascular endothelial cells. In support of other studies
which have demonstrated the interaction between NMV and other endothelial cells, such as HUVEC
andHCAEC [29,43], our study using confocal microscopy and flow cytometry confirmed the interaction
and subsequent uptake of NMV by hCMEC/D3 cells. It should be noted that while flow cytometry
is a standard approach to quantitate the number of cells that have internalized NMV, it does not
discriminate between single or multiple NMV uptake. Once internalized, NMV associate with early
endosomal compartments, as demonstrated by the co-localization with EEA-1, supporting the role of
endocytosis as major route of entry [46,48]. EEA-1 is an early endosomal protein that has been linked
with endocytic vesicles before the fusion with early endosomes [49]. However, only a small proportion
of NMV co-localized with EEA-1, while the majority were found near to endosomes. Real time tracking
of MV through the cell is needed to understand the fate of NMV after they are internalized and
localized in the endosome.
To understand the mechanism of internalization, initially, we investigated whether the process is
broadly active or passive. Co-incubation of hCMEC/D3 with NMV at 4 ◦C almost completely inhibited
internalization, demonstrating that uptake is an energy-dependent process [47,50,51]. Furthermore,
treatment with proteinase K significantly reduced internalization, demonstrating that uptake likely
requires some form of initial surface binding. There are ongoing studies to identify the key proteins
present on the surface of MV [52] and further studies to identify which proteins are involved in the
recognition of, and binding to, target cells are required.
Uptake of NMV by hCMEC/D3 was partially inhibited by EDTA, a metal ion chelator,
suggesting that internalization may be partially calcium-dependent [46,53]. To further understand the
contribution of the endocytotic pathway toNMV internalization, we utilized pharmacological inhibitors.
Cytochalasin D depolymerizes actin, thereby preventing endocytosis [54], while dynasore is a GTPase
inhibitor that reversibly inhibits dynamin activity [55]. Both cytochalasin D and dynamin significantly
reduced internalization in hCMEC/D3, supporting the findings of other studies that have shown these
compounds reduce internalization of extracellular vesicles in other types of cells [46,48,56]. Notably,
both inhibitors did not completely inhibit the internalization of NMV uptake. These results together
indicate that NMV uptake is energy-dependent and requires cytoskeletal rearrangement, which are
both indicative of endocytic pathways. Furthermore, EIPA also significantly reduced internalization,
demonstrating a role for macropinocytosis in uptake, in agreement with the literature [46,50,56].
However, it should be noted that EIPA has an effect on cellular pH, which may also impact the
uptake of NMV [57]. Other inhibitors, including MDC, wortmannin (PI3-Akt pathway inhibitor), and
genistein, also had moderate effects on internalization. Interestingly, none of the chemical inhibitors
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completely inhibited internalization, possibly due to the heterogeneous nature of the NMV population.
NMV range in size from 100 to 1000 nm in diameter [25,26] and the multiple pathways employed for
internalization may suggest the mechanism of uptake of NMV is dependent on their size and surface
molecule expression [58,59]. However, further studies are required to fully elucidate these mechanisms.
We further demonstrate that inflammatory stimuli such as LPS and TNF-α did not alter NMV
internalization. In response to inflammatory stimuli, BMEC increase their expression of ICAM-1. While
blocking ICAM-1 reduces the uptake of extracellular vesicles in dendritic cells and HCAEC [29,60],
other studies report blocking ICAM-1/VCAM-1 does not reduce internalization of platelet-derived MV
by BMECs [46]. Together, these studies highlight that the origin of MV and their target cells play a
significant role in the way that MV are internalized.
Various methods of stimulation have been shown to elicit the formation of NMV that affect
other target cells, such as endothelial cells [32,61,62] and macrophages [25,63]. NMV impact the gene
expression profile of HUVEC [43], and in the current study, we demonstrate that NMV significantly
change the transcriptomic profile of human brain endothelial cells. Specifically, NMV induced
dysregulation in expression of tight junction proteins, p38 pathway, and SNARE-mediated vesicular
transport. One of the differentially expressed genes, Tumor Protein P53 Inducible Nuclear Protein 1
(TP53INP1), is a downstream target for miR155 [64] which is enriched in NMV [29]. Other dysregulated
genes, including transforming growth factor β receptor 1 (TGF-βR1), BH3- interacting domain 1 (BID1),
and mitogen activated protein kinase kinase kinase (MAP3K), are involved cellular apoptosis and
inflammation and can affect vascular integrity [65–68].
In support of our transcriptomic data, functional studies confirmed thatNMVsignificantly decrease
the integrity and significantly increase the permeability of a confluent monolayer of hCMEC/D3,
supporting studies which have demonstrated increased disruption of the BBB by MV isolated from
the plasma in vitro [69] and exosomes in vivo [70]. While our results confirm previous findings that
hCMEC/D3 have a TEER ranging from 20 to 30 Ω/cm2 [71,72], it should be noted that this does not
reflect the TEER of the BBB in vivo, which ranges between 1500 and 2000 Ω/cm2 [73]. Many methods
have been used to increase the TEER in hCMEC/D3, including co-culturing with astrocytes [74] and
growing them under sheer stress [75], which increases TEER slightly. Nonetheless, hCMEC/D3 is a
robust, commonly utilized model of the BBB [72,76–78].
Systemic inflammation is known to modulate BBB function, and MV have been shown to increase
endothelial permeability [79,80]. When the BBB is disturbed, the flux of tracer molecules increases
through the cell monolayer [81], thereby allowing us to utilize this effect to study the changes in
permeability. Here we report that NMV significantly increase the flux of FITC-dextran (both 10 kDa
and 70 kDa) through a confluent monolayer of hCMEC/D3. The change in flux of 10 kDa FITC-dextran
was greater than that for 70 kDa, suggesting that NMV have a greater effect on the flux of smaller
molecules through the monolayer. Notably, most cytokines have small molecular weights [82] and
increased flux of cytokines across the BBB can modulate the neuroinflammatory response [83,84].
In summary, we have shown that the internalization of NMV significantly impacts the
transcriptomic profile of hCMEC/D3 cells, including the dysregulation of genes associated with
tight junctions and vesicular transport, and significantly increases the permeability and decreases
the TEER of a monolayer of brain endothelial cells. This internalization process is energy-dependent
and uses multiple endocytic pathways. NMV are being increasingly studied as therapeutic targets.
Neutrophils exhibit considerable plasticity and are responsive to bidirectional signaling [85], therefore
it may be possible to modulate the peripheral immune response, in particular, neutrophils, to influence
therapeutic outcomes in AD. Understanding the effects of NMV on the BMEC could identify a potential
mechanism linking systemic inflammation and accelerated cognitive decline in dementia patients,
however further work is required to assess the impact of NMV on the BMEC in a relevant animal
model in vivo and to characterize the content of NMV. In conclusion, this study provides novel insights
into the role of NMV in BMEC dysfunction.
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4. Materials and Methods
4.1. Cell Culture
hCMEC/D3 cells were obtained from Cedarlane, Canada and were cultured in EBM-2 medium
with 2.5% FBS and supplemented with vascular endothelial growth factor (VEGF), insulin-like growth
factor (IGF-1), human epidermal growth factor (hFGF), human basic fibroblast growth factor (hFGF),
hydrocortisone, and ascorbic acid (all provided in EGM-2 MV bulletkit, Lonza, Basel, Switzerland).
Cells were cultured on Collagen type-I (Sigma, Gillingham, UK) coated plates. All experiments were
carried out between passage 27–35.
4.2. Neutrophil-Derived Microvesicle Isolation
Venous blood was obtained from consenting healthy volunteers over the age of 18 with no
known medical conditions following ethical approval from the University of Sheffield Research Ethics
Committee (referenceNo: SMBRER310, Date of approval, 1/05/2014). Peripheral blood neutrophilswere
isolated based on the protocol by Timar et al. [86] with minor modifications. Briefly, peripheral venous
blood was collected in tubes containing 3.8% sodium citrate and was separated by density gradient
centrifugation using Histopaque-1077 (Cambridge Bioscience, Cambridge, UK). Red blood cells were
lysed, and isolated neutrophils were stimulated with the bacterial-derived peptide fMLP (10 µmol/L,
Sigma) for 1 h (37 ◦C in 5% CO2). Neutrophils and large cell debris were pelleted by centrifugation
(500× g for 5 min followed by 1500× g, 5 min respectively). A sample was taken for cytospin to check
for any cellular contamination. The supernatant was centrifuged at 20,000× g for 30 min to pellet NMV.
The pelleted NMV were resuspended in 0.2-µm sterile-filtered PBS. The number of NMV from each
isolation was determined using a BD LSRII flow cytometer (Becton Dickinson, Wokingham, UK). The
settings were standardized on forward-scatter and side-scatter gates using Megamix beads of various
sizes (0.5, 0.9, 3 µm, BioCytex, Marseille, France). NMV were quantified using Sphero™AccuCount
beads (Saxon Europe, Kelso, UK). The flow cytometer was set to count 1000 beads and the concentration
of NMV in the sample was calculated using the manufacturer’s instructions.
4.3. Flow Cytometric Analysis
NMV were resuspended in PBS and incubated with either FITC-Annexin V (according to
manufacturer’s instructions, Biolegend, London, UK), mouse anti-human CD66b (1 µg/mL, Clone:
G10F5, BD Bioscience), CD14 (0.75 µg/ ml, Clone: M5E2, BD Bioscience) fluorescently-conjugated
antibodies or appropriate isotype controls for 45 min in the dark at 4 ◦C. Labeling was assessed using a
BD LSRII flow cytometer (Becton Dickinson) and data was analyzed using FlowJo software (FlowJo
v10.3; Treestar Inc, Ashland, OR, USA).
4.4. Nanoparticle Tracking Analysis
Size distribution of NMVs was determined using nanoparticle tracking analysis. The ZetaView
(Particle Metrix, Meerbusch, Germany) was calibrated using 110 nm polystyrene beads (Thermofisher,
Runcorn, UK). NMVs were diluted in milliQ water and loaded into the cell. The frame rate was set to
3.75 frames/second and shutter speed of 70. Measurements were taken at 11 positions in the cell, with
2 cycles of each position. Data were then analyzed using Particle Metrix software (ZetaView 8.03.08.03)
and Microsoft Excel 2010 (Microsoft Corp., Washington, DC, USA).
4.5. Neutrophil Microvesicle Internalization by Endothelial Cells
NMVwere fluorescently labeled with PKH-26 or PKH-67 (Sigma) according to the manufacturer’s
instructions. NMV were pelleted by centrifugation (20,000× g, 30 min). Fluorescently-labeled
NMV (300 NMV/µL) were added to hCMEC/D3 cells plated on collagen type-I coated 24-well plates
(30,000 cells/well and grown to confluence) and incubated at 37 ◦C for 2 h. For flow cytometric analysis,
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cells were washed, trypsinised, and resuspended in PBS. 100 µL of trypan blue (1 mg/mL) was added
to each sample immediately prior to analysis on the flow cytometer to ensure the fluorescent signal
detected was only from internalized NMV [87]. Changes in mean fluorescence intensity and % positive
cells were analyzed using FACSDiva acquisition software version 8 (Becton Dickinson) and FlowJo
analysis software v10.3 (Treestar Inc, Ashland, OR, USA.
To determine PKH-26 localization, the cells were fixed with 4% paraformaldehyde for 10 min,
washed twice, and permeabilized with 0.1% Triton-X for 3 min. The cells were washed three times
and non-specific binding was blocked using 3% BSA for 30 min. Actin filaments were stained
using FITC-Phalloidin (1:200) and nuclei were counterstained using TOPRO-3-iodide (1 µg/mL, Life
Technologies, Paisley, UK).
For the co-localization experiment, hCMEC/D3 cellswere stainedusing antibodies to EEA-1 antigen
(SC-365652, 5µg/mL, SantaCruz Biotechnology, Heidelberg, Germany) and nuclei were counterstained
using Hoechst nuclear dye (1 µg/mL, Sigma). Localization of NMV was visualized using a Zeiss KSM
880 with an Airyscan confocal microscope and images were obtained using Zeiss Leica Zen imaging
software (Leica, Milton Keynes, UK).
4.6. Analysis of Internalization Pathways
hCMEC/D3 cells were plated as described above. To determine if inflammatory stimuli such as
TNF-α or LPS influence the rate of internalization, cells were preincubated with TNF-α (10 ng/mL) or
LPS (1 µg/mL) 16 h before adding NMV.
For inhibition experiments, EIPA (50 µM), EDTA (0.1 µM), or cytochalasin D (1 µM) were added
to the wells 30 min prior to NMV addition, while monodansylcadaverine (MDC) (150 µM) or Dynasore
(1 µM) were added 1 h prior. Cells were preincubated for 1 h with genistein (100 µM) and wortmannin
(1 µM), which removed by aspiration before the addition of NMV. For proteinase K (150 ug/mL), cells
were pre-incubated for 30 min and washed once with PBS before adding NMV. The mean fluorescence
intensity was measured by flow cytometry as described above.
4.7. RNA Extraction and Amplification
hCMEC/D3 cells were incubated with NMV for 24 h and RNA was extracted using the Direct-zol
RNA kits (Cambridge Bioscience), according to the manufacturer’s instructions. The quantity and
quality of the extracted RNA were determined using Nanodrop 1000 spectrophotometer (Thermo
Fisher Scientific, Altrincham, UK) and a 2100 Bioanalyzer (Agilent, Stockport, UK).
4.8. Microarray Amplification and Microarray Hybridization
For RNA amplification, the GeneChip 3′ IVT Express amplification protocol (Thermo Fisher
Scientific) was used. Briefly, 100 ng of total RNA was annealed to an oligo-d(T) primer with a T7
polymerase binding site. After the generation of double-stranded complementary DNA (cDNA), copy
RNA (cRNA) was transcribed, which acted as the RNA template for second round amplification.
At the end of this round, biotin-labeled cRNA was prepared using the Affymetrix Gene Chip
in vitro transcription labelling kit (Affymetrix). The RNA quality was assessed after the clean-up of
biotin-labeled cRNA using Agilent Bioanalyser 2100 (Agilent) 12.5ug of labeled antisense RNA was
fragmented and 11 µg applied to HGU133 Plus 2.0 gene microarrays and hybridized over 16 h at 45 ◦C
in a rotating oven at 60 rpm. Post-hybridization washing and sample staining was carried out using
FluidicStation400 (Thermo Fisher Scientific) and the Gene Chip Operating System (Thermo Fisher
Scientific) and was scanned using a GC3000 7G scanner (Thermo Fisher Scientific).
4.9. Microarray Analysis
The RobustMulti-arrayAverage (RMA)was used to determine intensity distribution and eliminate
sample outliers [88]. Microarray analysis was carried out using Qlucore Omics Explorer (Qlucore,
Lund, Sweden) and setting the parameters of significantly differentially expressed genes as p ≤ 0.05 and
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fold change of minimum 1.2. Functional analysis was performed using the Database for Annotation
Visualization and Integrated Discovery (DAVID) and PANTHER to group the genes according to their
function and functional pathways.
4.10. Permeability Assay
To assess monolayer permeability, hCMEC/D3 cells were cultured on 24 well transwell inserts
(0.4 µm pores, PET, Starsstead) to confluence for 4 days. To measure the barrier integrity, FITC-dextran
of 10 kDa and 70 kDa (1 mg/mL, Sigma) was added to the apical chamber in phenol red-free media.
Samples (100 µL) were taken from the basolateral chamber at times 0, 6, and 24 h. The equivalent
volume of phenol red-free medium was added back to the chamber to compensate for the reduction
in volume due to sampling. Transwell inserts without cells were included as controls for membrane
interference. Fluorescence was measured using a plate reader with excitation at 492 nm and emission
at 520 nm.
4.11. Transendothelial Electrical Resistance (TEER)
Transwell inserts were coated with collagen-I were used to seed hCMEC/D3 cells grown
to confluence. TEER was measured in triplicates using the STX01 electrode and Millicell- ERS
Volt-Ohmmeter. NMV (300/µL) were added to the apical side and three readings were taken every
hour for 6 h, and the average was used to calculate TEER. LPS (1 µg/mL) was used as a positive control.
4.12. Statistical Analysis
All statistical analysis was performed using GraphPad Prism version 7.00 (Graphpad software,
San Diego, CA, USA). Results are presents as mean ± standard deviation unless otherwise stated.
Analyses used are indicated in each figure legend.
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